Canon is developing activities to support medical institutions. These activities include donating X-ray CT diagnostic equipment for clinical testing of pneumonia, and research on the practical application of a rapid genetic testing system for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Contribution through business activities


Canon Medical Systems Corporation
  • In response to a request from the government of Cusco, Peru, where the number of patients with COVID-19 has been increasing rapidly, the delivery of a state-of-the-art CT system, Aquilion ONE/PRISM Edition, was made in a short period of time.
  • Installed COVID-19 testing system in the inboard inspection room of cruise ships.
  • Support for on-site COVID-19 testing during the Diving World Cup.
  • Canon Medical Systems and Sansei, an engineering company based in Yokohama, start collaboration of mobile medical container for testing SARS-CoV-2 (COVID-19).
  • Launch of the LAMPdirect / Genelyzer KIT, a set of reagents for SARS-CoV-2 (COVID-19) RNA testing, which enables detection within about 30 minutes of sampling.
  • Launch of the Rapiim SARS-CoV-2-N, a qualitative antigen test kit.
  • Release of Mobile Medical Container CT Equipped with Measures to Prevent the Spread of Infectious Disease
  • Launch of the Genelyzer F-MS kit that enables simultaneous testing of 96 samples.
  • Launch of the Genelyzer KIT, a set of reagents for SARS-CoV-2 (COVID-19) RNA testing for research use.
  • Participation in an empirical study on the usefulness of early diagnosis of COVID-19 pneumonia using a CT-equipped vehicle.
  • Start of clinical evaluation of new technology to improve the diagnosis of novel coronavirus pneumonia.
  • Canon Medical Systems, in cooperation with Nagasaki University, has successfully developed a rapid genetic testing system with practical application for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
  • Americas

    Canon Virginia, Inc.
    With a continuing need for at-home testing kits across the States, Canon Virginia (CVI) has joined MaximBio to start assembling ClearDetect COVID-19 Antigen Home Test Kits at CVI's facility in Newport News, Virginia, with production starts in early May, 2022.